[go: up one dir, main page]

WO2009078978A3 - Compositions containing polyglycidol-based polymers and uses thereof - Google Patents

Compositions containing polyglycidol-based polymers and uses thereof Download PDF

Info

Publication number
WO2009078978A3
WO2009078978A3 PCT/US2008/013728 US2008013728W WO2009078978A3 WO 2009078978 A3 WO2009078978 A3 WO 2009078978A3 US 2008013728 W US2008013728 W US 2008013728W WO 2009078978 A3 WO2009078978 A3 WO 2009078978A3
Authority
WO
WIPO (PCT)
Prior art keywords
polyglycidol
compositions containing
based polymers
treatment
acceptable carrier
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2008/013728
Other languages
French (fr)
Other versions
WO2009078978A2 (en
Inventor
Lorraine Reeve
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Phrixus Pharmaceuticals Inc
Original Assignee
Phrixus Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phrixus Pharmaceuticals Inc filed Critical Phrixus Pharmaceuticals Inc
Publication of WO2009078978A2 publication Critical patent/WO2009078978A2/en
Publication of WO2009078978A3 publication Critical patent/WO2009078978A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The present invention provides a therapeutic composition for treatment of heart failure, comprising a therapeutically acceptable carrier and a polyglycidol-based polymer as a therapeutic agent.
PCT/US2008/013728 2007-12-14 2008-12-15 Compositions containing polyglycidol-based polymers and uses thereof Ceased WO2009078978A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1375607P 2007-12-14 2007-12-14
US61/013,756 2007-12-14

Publications (2)

Publication Number Publication Date
WO2009078978A2 WO2009078978A2 (en) 2009-06-25
WO2009078978A3 true WO2009078978A3 (en) 2009-12-03

Family

ID=40638191

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2008/013728 Ceased WO2009078978A2 (en) 2007-12-14 2008-12-15 Compositions containing polyglycidol-based polymers and uses thereof

Country Status (1)

Country Link
WO (1) WO2009078978A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103222984A (en) 2006-08-01 2013-07-31 普里克萨斯医药股份有限公司 Treatment for chronic progressive heart failure
US8372387B2 (en) 2007-04-05 2013-02-12 Phrixus Pharmaceuticals, Inc. Compositions and methods for the treatment of heart failure
DE102011076019A1 (en) * 2011-05-18 2012-11-22 Evonik Goldschmidt Gmbh Alkoxylation products and processes for their preparation by means of DMC catalysts
WO2022013642A1 (en) * 2020-07-16 2022-01-20 3M Innovative Properties Company Phosphate-containing copolymers for virulence suppression
WO2024142845A1 (en) * 2022-12-28 2024-07-04 株式会社 資生堂 Oily cosmetic composition
WO2024142843A1 (en) * 2022-12-28 2024-07-04 株式会社 資生堂 Cosmetic composition
WO2024142849A1 (en) * 2022-12-28 2024-07-04 株式会社 資生堂 Water-in-oil emulsion cosmetic composition
WO2024142848A1 (en) * 2022-12-28 2024-07-04 株式会社 資生堂 Cosmetic composition

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
HALACHEVA S., RANGELOV S., TSVESTANOV C.: "Poly(glycidol)-based analogues to pluronic block copolymers. Synthesis and aqueous solution properties", MACROMOLECULES, vol. 39, 2006, US, pages 6845 - 6852, XP002549306 *
KAINTHAN RAJESH KUMAR ET AL: "Biocompatibility testing of branched and linear polyglycidol", BIOMACROMOLECULES, vol. 7, no. 3, March 2006 (2006-03-01), pages 703 - 709, XP008113075, ISSN: 1525-7797 *
TOWNSEND DEWAYNE ET AL: "Cardiomyopathy of Duchenne muscular dystrophy: pathogenesis and prospect of membrane sealants as a new therapeutic approach.", EXPERT REVIEW OF CARDIOVASCULAR THERAPY JAN 2007, vol. 5, no. 1, January 2007 (2007-01-01), pages 99 - 109, XP008113086, ISSN: 1744-8344 *
YASUDA SOICHIRO ET AL: "Dystrophic heart failure blocked by membrane sealant poloxamer", NATURE, NATURE PUBLISHING GROUP, LONDON, UK, vol. 436, no. 7053, 18 August 2005 (2005-08-18), pages 1025 - 1029, XP002495265, ISSN: 0028-0836 *

Also Published As

Publication number Publication date
WO2009078978A2 (en) 2009-06-25

Similar Documents

Publication Publication Date Title
WO2009078978A3 (en) Compositions containing polyglycidol-based polymers and uses thereof
WO2009129246A3 (en) Compositions and methods for preparing and using same
WO2010007116A3 (en) Pyridons as pdk1 inhibitors
IL225198A (en) Aminotetrahydropyran compounds, pharmaceutical compositions comprising the same and the use thereof for the treatment of diabetes
WO2010005721A3 (en) Drug loaded polymeric nanoparticles and methods of making and using same
WO2009152356A3 (en) Compounds and compositions useful for the treatment of malaria
WO2009067686A3 (en) Sunitinib hemi-l-malate, polymorphs and preparation thereof, polymorphs of racemic sunitinib malate, compositins containing sunitinib base and malic acid and preparation thereof
WO2007112014A3 (en) New therapeutic combinations for the treatment of depression
WO2009055306A3 (en) Coating designs for the tailored release of dual drugs from polymeric coatings
WO2009003999A3 (en) Chemical compounds
WO2010068862A3 (en) Zwitterionic polymers with therapeutic moieties
WO2008148074A3 (en) Inhibitors of mtor and methods of treatment using same
WO2010039977A3 (en) Heteroaryl antagonists of prostaglandin d2 receptors
WO2007147010A3 (en) Implantable medical devices and methods for making the same
WO2008121348A3 (en) Peripheral opioid receptor antagonists and uses thereof
IL210549A (en) Substituted- quinoxaline-type bridged-piperidine compounds, compositions comprising them and uses thereof for the manufacture of medicaments
WO2010067078A3 (en) 3,6-disubstituted xanthylium salts as medicaments
WO2009085277A3 (en) Use of anti-connexin 43 polynucleotides for the treatment of abnormal or excessive scars
WO2009019294A3 (en) Bupropion hydrobromide and therapeutic applications
WO2010121164A3 (en) 1,4-benzodiazepinone compounds and their use in treating cancer
WO2008008700A3 (en) Substituted cyclopentane derivatives as therapeutic agents
WO2010012745A3 (en) Benzimidazoles
WO2007133944A3 (en) Topical administration of acyclovir
WO2009061811A8 (en) Substituted cyclopentanes having prostaglanding activity
WO2008125800A3 (en) Mmp activated vascular disrupting agents

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08862037

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08862037

Country of ref document: EP

Kind code of ref document: A2